Search Results

Displaying Results 3276-3300 of 130544 "'OR'"

Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Globant SA of Class Action Lawsuit and Upcoming Deadlines - GLOB

lawsuit has been filed against Globant SA ("Globant" or the "Company") (NYSE: GLOB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exzeo Group, Inc. - XZO

claims on behalf of investors of Exzeo Group, Inc. ("Exeo" or the "Company") (NYSE: XZO).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of B&G Foods, Inc. - BGS

on behalf of investors of B&G Foods, Inc. ("B&G" or the "Company") (NYSE: BGS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sigma Lithium Corporation - SGML

investors of Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ: SGML).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA

claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC

regarding the Company's business, operations, and compliance policies.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Regencell was vulnerable and/or subject to market manipulation; (ii) the resulting volatility in the market for the Company's ordinary shares

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Black Rock Coffee Bar, Inc. - BRCB

of investors of Black Rock Coffee Bar, Inc. ("Black Rock" or the "Company") (NASDAQ: BRCB).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN

investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ZoomInfo Technologies Inc. - GTM

behalf of investors of ZoomInfo Technologies Inc. ("ZoomInfo" or the "Company") (NASDAQ: GTM).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in POET Technologies Inc. of Class Action Lawsuit and Upcoming Deadlines - POET

been filed against POET Technologies Inc. ("POET" or the "Company") (NASDAQ: POET).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Stellantis N.V. of Class Action Lawsuit and Upcoming Deadlines - STLA

been filed against Stellantis N.V. ("Stellantis" or the "Company") (NYSE: STLA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Calix, Inc. of Class Action Lawsuit and Upcoming Deadlines - CALX

lawsuit has been filed against Calix, Inc. ("Calix" or the "Company") (NYSE: CALX).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP

has been filed against Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SES AI Corporation of Class Action Lawsuit and Upcoming Deadlines - SES

has been filed against SES AI Corporation ("SES AI" or the "Company") (NYSE: SES). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in zSpace, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZSPC

lawsuit has been filed against zSpace, Inc. ("zSpace" or the "Company") (NASDAQ: ZSPC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forward Air Corporation - FWRD

behalf of investors of Forward Air Corporation ("Forward Air" or the "Company") (NASDAQ: FWRD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ChampionX Corporation of Class Action Lawsuit and Upcoming Deadlines - CHX

filed against ChampionX Corporation ("ChampionX" or the "Company") (NASDAQ: CHX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB

investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merchants Bancorp - MBIN

behalf of investors of Merchants Bancorp ("Merchants Bancorp" or the "Company") (NASDAQ: MBIN).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Futu Holdings Limited - FUTU

on behalf of investors of Futu Holdings Limited ("Futu" or the "Company") (NASDAQ: FUTU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN

investigating claims on behalf of investors of Qiagen N.V. ("Qiagen" or the "Company") (NYSE: QGEN).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

claims on behalf of investors of Oculis Holding AG ("Oculis" or the "Company") (NASDAQ: OCS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Upwork Inc. - UPWK

investigating claims on behalf of investors of Upwork Inc. ("Upwork" or the "Company") (NASDAQ: UPWK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fitness Champs Holdings Ltd. of Class Action Lawsuit and Upcoming Deadlines - FCHL

filed against Fitness Champs Holdings Ltd. ("FCHL" or the "Company") (NASDAQ: FCHL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire

More news about: Pomerantz LLP


Jun 04, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH

investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

More news about: Pomerantz LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.